These are the KEI comments on the questions raised by the FDA in the 85 FR 33165 and 85 FR 33169 Federal Register notices. KEI-comments-FDAOrange Book-31aug2020 KEI comments to the FDA relating to the Approved Drug Products With Therapeutic Equivalence… Continue Reading
KEI Research Note: 2020-4: The current and potential role of biomedical research mandates 2020 The current and potential role of biomedical research mandates. Progress in biomedical research depends upon funding. This funding comes from a variety of public sector, non-profit… Continue Reading
On 29 June 2020, the World Health Organization (WHO) published a document (A73/INF./3, 29 June 2020), entitled, “Voluntary contributions by fund and by contributor, 2019“. Total voluntary contributions to WHO’s Total General Fund in 2019 amounted to $2,443,961,432; in 2018,… Continue Reading
On 30 July 2020, the World Trade Organization (WTO) convened a formal meeting of the TRIPS Council. The TRIPS Council held discussions on two COVID-19 related topics: agenda item 3 on IP Measures in the Context of COVID-19 and agenda… Continue Reading
Knowledge Ecology International (KEI), the Center for Digital Democracy (CDD), and three individuals, Manon Ress, Professor Liza Vertinsky, from Emory Law School and Dr. Reshma Ramachandran, a fellow at Yale University School of Medicine, have filed a citizens petition with… Continue Reading
On 30 July 2020, the World Trade Organization (WTO) convened a formal meeting of the TRIPS Council. The TRIPS Council held discussions on two COVID-19 related topics: agenda item 3 on IP Measures in the Context of COVID-19 and agenda… Continue Reading
Below is a letter from several individuals and groups, asking that NIAID not grant exclusive rights in a HIV patent license for South Africa, India and other low income countries. (PDF version here) The license is to RNAceuticals, a firm… Continue Reading
On Friday, 17 July 2020, South Africa submitted a paper to the World Trade Organization (WTO) TRIPS Council entitled, Intellectual Property and the Public Interest: Beyond Access to Medicines and Medical Technologies Towards a More Holistic Approach To TRIPS Flexibilities.… Continue Reading
KEI has a number of outstanding requests under the United States Freedom of Information Act (FOIA) for contracts related to biomedical innovations to control or treat the COVID-19 pandemic. On Thursday, June 25, and Friday, June 26, we received a… Continue Reading
On Friday, 19 June 2020, the World Trade Organization (WTO) convened an informal virtual Open-ended Meeting of the TRIPS Council. . The following statements were delivered by South Africa at the virtual open-ended informal meeting of the TRIPS Council. In… Continue Reading